sglt2 inhibitors and cardiovascular outcomes in type 2 diabetes: vertis cv trial
Published 2 years ago • 93 plays • Length 7:14Download video MP4
Download video MP3
Similar videos
-
5:20
sglt2 inhibition and cvd outcomes in type 2 diabetes
-
5:05
sglt2 inhibitors: cv outcomes data in type 2 diabetes
-
10:37
cardiovascular outcomes in new users of sglt-2 inhibitors
-
8:15
sglt2 inhibitors and heart failure
-
22:15
sglt-2 inhibitors for type 2 diabetes - amel arnaout, md
-
1:23:07
sglt2 inhibitors & cardiovascular outcome
-
2:09
cardiovascular outcomes in patients with diabetes
-
34:54
professor stephen wiviott - 'sglt2 outcome trials - an evolving story'
-
10:11
expert commentary: the vertis-cv trial | francesco giorgino
-
13:49
using sglt2-inhibitors to treat cardiac patients with diabetes
-
2:27
cardiovascular benefit with sglt2 inhibition
-
1:06:15
a tale of salt and sugar: sglt2 inhibitors in cardiovascular disease
-
2:59
assimilating the evidence in t2dm: cardiovascular and renal outcomes with sglt2 inhibitors
-
6:11
benefits of sglt2 inhibitors and glp-1 receptor agonists
-
14:06
sglt2 inhibitors: the story so far | john wilding
-
50:30
protocols for safe use of sglt2i and glp1ra in the hospital setting
-
27:44
are there alternative mechanisms to explain sglt2i beneficial cveffects in some patients?
-
29:16
the implications of the latest data on sglt2 inhibitors in heart failure: a unified approach to t...
-
25:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - full presentation